Cellular & Molecular Immunology

Cellular & Molecular Immunology is a monthly peer-reviewed journal founded in 2004 by the Chinese Society of Immunology and published by Springer Nature, covering basic and clinical immunology, with a 2025 Journal Impact Factor of 23.9《细胞与分子免疫学》是（Chinese Society of Immunology）2004 年创办、（Springer Nature）出版的月度同行评审期刊，涵盖基础与临床免疫学，2025 年影响因子为 23.9。

Scope

• It covers both basic immunology research and clinical applications, reporting advances in understanding the host immune response in vitro and in vivo该刊兼顾基础免疫学研究与临床应用，报道对宿主免疫应答在体外与体内理解的最新进展。
• Subject areas include clinical immunology, immunobiology, immunogenetics, immunopathology and immunopharmacology学科领域包括临床免疫学、免疫生物学、免疫遗传学、免疫病理学与免疫药理学。
• Coverage also spans infection immunology, neuroimmunology, transplantation immunology and tumor immunology其报道还涵盖感染免疫学、神经免疫学、移植免疫学与肿瘤免疫学。^[1]
• It publishes Articles, Review Articles, Mini Reviews, Short Communications and Correspondences该刊刊载研究论文、综述、迷你综述、短篇通讯与通信。
• As China's first English-language immunology journal, it serves both Chinese and international communities作为中国首本英文免疫学期刊，它同时服务中国与国际学术共同体。
• It welcomes novel or unorthodox approaches provided they are supported by conventional scientific practice and testable hypotheses该刊欢迎新颖或非正统的思路，但须以常规科学实践与可检验的假设为支撑。

History

• Cellular & Molecular Immunology was launched in February 2004 and is published monthly《细胞与分子免疫学》于 2004 年 2 月创刊，按月出版。
• It is co-sponsored by the Chinese Society of Immunology and the University of Science and Technology of China该刊由（Chinese Society of Immunology）与（University of Science and Technology of China）共同主办。
• Its editorial policies are determined jointly by its editorial board and Springer Nature其编辑政策由编委会与（Springer Nature）共同制定。
• It was founded as the first English-language immunology journal based in China该刊创刊时即为中国首本英文免疫学期刊。
• Its 2025 Journal Impact Factor is 23.9, ranking fifth among 183 immunology journals, with a five-year impact factor of 27.6其 2025 年影响因子为 23.9，在 183 种免疫学期刊中排名第五，五年影响因子为 27.6。
• It is indexed in MEDLINE, PubMed and the Science Citation Index Expanded, among other databases该刊被 MEDLINE、PubMed 与 SCIE 等数据库收录。

Editors

• The journal is led by co-editors-in-chief Xuetao Cao of Second Military Medical University and Zhigang Tian of the University of Science and Technology of China该刊由（Second Military Medical University）的曹雪涛与（University of Science and Technology of China）的田志刚共同担任主编。
• The deputy editor-in-chief is Rongbin Zhou of the University of Science and Technology of China副主编为（University of Science and Technology of China）的周荣斌。
• Associate editors-in-chief include Antonio Bertoletti, Hongbo Chi, Bin Gao and Dieter Kabelitz, from institutions in Singapore, the United States, Croatia and Germany助理主编包括 Antonio Bertoletti、Hongbo Chi、Bin Gao 与 Dieter Kabelitz，来自新加坡、美国、克罗地亚与德国的机构。
• The editorial board spans the full breadth of cellular and molecular immunology and includes members from many countries编委会覆盖细胞与分子免疫学的完整范围，成员来自多个国家。
• The journal follows the principles of the Committee on Publication Ethics该刊遵循出版伦理委员会（COPE）的原则。
• In 2025 the median time from submission to first editorial decision was 6 days and to acceptance was 146 days2025 年，从投稿到首次编辑决定的中位时间为 6 天，到接收为 146 天。